Type I and type II T-cell profiles in aplastic anemia and refractory anemia

被引:6
|
作者
Tsuda, H [1 ]
Yamasaki, H [1 ]
机构
[1] Kumamoto City Hosp, Div Clin Hematol & Immunol, Kumamoto 8628505, Japan
关键词
pathogenesis; immune mechanism; T-cell subset; aplastic anemia; myelodysplastic syndrome; refractory anemia;
D O I
10.1002/1096-8652(200008)64:4<271::AID-AJH6>3.0.CO;2-C
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune-mediated suppression of hematopoiesis has been considered the most important mechanism in the development of idiopathic aplastic anemia (AA) and some types of myelodysplastic syndrome (MDS). Using flow cytometric analysis of intracellular cytokine expression at the single-cell level, we analyzed helper-T (Th) and cytotoxic-T (Tc) subsets in patients with AA and MDS of refractory anemia (RA) subtype. The results showed marked increases in the Th1/Th2 ratio and Tc1/Tc2 ratio in both AA and MDS/RA. Overproduction of cytokines inhibitory to hematopoiesis reported so far might be a reflection of imbalanced development of Th and Tc. Determination of the factors that affect Th and Tc profiles may lead to further understanding of immunological states and the development of effective immunotherapy in AA as well as some types of MDS. Am. J. Hematol. 64:271-274, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:271 / 274
页数:4
相关论文
共 50 条
  • [31] Clinical Significance of Chromosomal Abnormalities in Patients with Aplastic Anemia and Refractory Anemia Deduced From the Prevalence of PNH-Type Cells.
    Sugimori, Naomi
    Yamazaki, Hirohito
    Sugimori, Chiharu
    Ishiyama, Ken
    Katagiri, Takamasa
    Nakao, Shinji
    BLOOD, 2009, 114 (22) : 447 - 447
  • [32] Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia
    Zhu, Caiying
    Lian, Yu
    Wang, Chenchen
    Wu, Peng
    Li, Xuan
    Gao, Yan
    Fan, Sibin
    Ai, Lanlan
    Fang, Liwei
    Pan, Hong
    Cheng, Tao
    Shi, Jun
    Zhu, Ping
    BLOOD, 2021, 138 (01) : 23 - 33
  • [33] A Promising New Treatment for Refractory Aplastic Anemia
    Metcalf, Donald
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (01): : 74 - 75
  • [34] Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
    Olnes, Matthew J.
    Scheinberg, Phillip
    Calvo, Katherine R.
    Desmond, Ronan
    Tang, Yong
    Dumitriu, Bogdan
    Parikh, Ankur R.
    Soto, Susan
    Biancotto, Angelique
    Feng, Xingmin
    Lozier, Jay
    Wu, Colin O.
    Young, Neal S.
    Dunbar, Cynthia E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (01): : 11 - 19
  • [35] CYCLOSPORINE A IN REFRACTORY SEVERE APLASTIC-ANEMIA
    GLENN, LD
    KLASSEN, LW
    BJORLING, VG
    CLINICAL RESEARCH, 1989, 37 (04): : A901 - A901
  • [36] CYCLOSPORINE IN REFRACTORY SEVERE APLASTIC-ANEMIA
    STRYCKMANS, PA
    DUMONT, JP
    VELU, T
    DEBUSSCHER, L
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (10): : 655 - 656
  • [37] CYCLOSPORINE IN REFRACTORY SEVERE APLASTIC-ANEMIA
    WISLOFF, F
    GODAL, HC
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (18): : 1193 - 1193
  • [38] Etanercept as a Salvage Treatment for Refractory Aplastic Anemia
    Dufour, Carlo
    Ciacchino, Raffaella
    Ghezzi, Pietro
    Tonelli, Rossella
    Ferretti, Elisa
    Pitto, A.
    Pistoia, Vito
    Lanza, Tiziana
    Svahn, Johanna
    PEDIATRIC BLOOD & CANCER, 2009, 52 (04) : 522 - 525
  • [39] EOSINOPHILIC FASCIITIS ASSOCIATED WITH REFRACTORY APLASTIC ANEMIA
    Patel, S.
    Hill, J. L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A59 - A60
  • [40] Congenital dyserythropoietic anemia type I
    Holla, R. G.
    Mishra, D. K.
    Prasad, A. N.
    INDIAN JOURNAL OF PEDIATRICS, 2010, 77 (02): : 215 - 216